## **Core Concept**
The question tests the understanding of the mechanism of action of statins, a group of cholesterol-lowering medications. Statins work by inhibiting a key enzyme in the biosynthesis of cholesterol. The enzyme in question is crucial in the hepatic production of cholesterol.

## **Why the Correct Answer is Right**
The correct answer, **HMG-CoA reductase**, is the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, a necessary step in the biosynthesis of cholesterol in the liver. Statins are competitive inhibitors of this enzyme, which leads to a decrease in cholesterol production in the liver, subsequently lowering the levels of LDL cholesterol in the blood.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to HMG-CoA reductase.
- **Option B:** This option is incorrect as it does not accurately represent the target of statins.
- **Option C:** This option is incorrect because it is not the enzyme targeted by statins.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the effectiveness of statins in reducing cardiovascular events is well-documented, but they can have side effects, including myopathy. The risk of myopathy can be increased by drug interactions that inhibit the cytochrome P450 system, particularly CYP3A4, which metabolizes many statins.

## **Correct Answer:** . HMG-CoA reductase